Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
2.000
-0.250 (-11.11%)
At close: Aug 16, 2024, 4:00 PM
2.080
+0.080 (4.00%)
After-hours: Aug 16, 2024, 7:59 PM EDT
Citius Oncology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Citius Oncology stock has a target of 6.00, which predicts an increase of 200.00% from the current stock price of 2.00.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for CTOR is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 |
---|---|
Strong Buy | 1 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
EF Hutton | EF Hutton | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +200.00% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.